维普期刊资源整合服务平台（V6.5）

36篇 您的检索式：作者名="AGATE L"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	All-trans-retinoic acid treatment inhibits the growth of retinoic acid receptor beta messenger ribonucleic acid expressing thyroid cancer cell lines but does not reinduce the expression of thyroid-specific genes显示文摘	Vivaldi A Agate L	2005	Clin Endocrinol Metab2005，90，4：	1
2	Outcome of differentiated thyroid cancer with detectable serum Tg and negative diagnostic 131 I whole body scan: comparison of treated with high 131 I active versus untreated patients显示文摘	Pacini F Agate L Elisei R		0，，：	1
3	Outcome of differentiated thyroid cancer with detectable serum Tg and negative 131Ⅰ whole body scan: comparison of patients treated with high 1hi activities versus untreated patients 显示文摘	Pacini F Agate L Elisei R	2001	J Clin Endocrinol Metab2001，86，9：	1
4	Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question 显示文摘	Elisei R Molinaro E Agate L	2010	J Clin Endoerinol Metab2010，95，4：	1
5	The HERO algorithm for ray tracing octrees显示文摘	AGATE M GRIMSDELE R L LISTER P F	1997	Advance in Computer Graphics Hardware1997，12，3：	1
6	All-trans-retinoic acid treatment inhibits the growth of retinoic acid receptor beta messenger ribonucleic acid expressing thyroid cancer cell lines but does not reinduce the expression of thyroid-specific genes 显示文摘	Elisei R Vivaldi A Agate L	2005	Clin Endocrinol Metab2005，90，4：	1
7	Outcome of differentiated thyroid cancer with detec-table serum Tg and negative diagnostic 131I whole body scan:comparison of trea-ted with high 131I activities versus untreated patients显示文摘	Pacini F Agate L Elisei R		0，，09：	1
8	New and old knowledge on differentiated thyroid cancer epidemiology and risk factors 显示文摘	Agate L Lorusso L Elisei R	2012	J Endocrinol Invest2012，35，6：	1
9	Low specificity ofblood thyroglobulin messenger ribonucleic acid assay preventsits use in the follow-up of differentiated thyroid cancerpatients显示文摘	ELISEI R VIVALDI A AGATE L	2004	J Clin Endocrinol Metab2004，89，1：	1
10	Outcome of differentiated thyroid cancer with detectable serum Tg and negative 131I whole body scan: comparison of patients treated with high 131I activities versus untreated patients显示文摘	Pacini F Agate L Elisei R Capezzone M Ceccarelli C Lippi F Molinaro E Pinchera A	2001	J Clin Endocrinol Metab2001，86，9：	1
11	Outcome of differentiated thyroid cancer with detectable serum thyroglobulin and negative diagnostic (131)I whole body scan: comparison of patients treated with high (131)I activities versus untreated patients显示文摘	Pacini F Agate L Elisei R	2001	J Clin Endocr Metab2001，86，9：	1
12	New and old knowledge on differentiated thyroid cancer epidemiology and risk factors显示文摘	Agate L Lorusso L Elisei R	2012	J Endocrinol Invest2012，356，：	1
13	Outcome of differentiated thyroid cancer with detectable serum Tg and negative diagnostic(131)I Whole body scan:comparison of patients treated with high(131)I activities versus untreated patients显示文摘	Pacini F Agate L Elisei R	2001	J Clin Endocrinol Metab2001，86，9：	1
14	Outcome of differentiated thyroid cancer with detectable serum Tg and negative ^131I whole body scan:comparison of patients treated with high ^131I activities versus untreated patients显示文摘	Pacini L Agate R Elisei M	2001	J Clin Endocrinol Metab2001，86，9：	1
15	New and old knowledge on differentiated thyroid cancer ~idemiolo~ and risk factors显示文摘	Agate L Lorusso L Elisei R	2012	J End~rin0i ~Vest2012，35，6：	1
16	Patients with differentiated thyroid cancer who underwent radioiodine thyroid remnant ablation with low-activity 31I after either recombinant human TSH or thyroid hormone therapy withdrawal showed the same outcome after a 10- year follow-up显示文摘	Molinaro E Giani C Agate L	2013	J Clin Endocrinol Metab2013，98，7：	1
17	New and old knowledge on differentiated thyroid cancer epidemiology and risk factors显示文摘	Agate L Lorusso L Elisei R	2012	J Endocrinol Invest2012，35，6：	1
18	New and old knowledge on differentiated thyroid cancer epidemiology and risk factors显示文摘	Agate L Lorusso L Elisei R	2012	J Endocrinol Invest2012，35，：	1
19	Patients with differentiated thyroid cancer who underwent radioiodine thyroid remnant ablation with low- activity 131I after either recombinant human TSH or thyroid hormone therapy withdrawal showed the same outcome after a 10 - year follow-up 显示文摘	Molinaro E Giani C Agate L	2013	J Clin Endocrinol Metab2013，98，7：	1
20	RET protein expression has no prognostic impact on the long-term outcome of papillary thyroid carcinoma 显示文摘	Molinaro E Agate L	2001	Eur J Endocrinol2001，，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示